$108.32
0.0% Today
as of Sep 4, 16:45 ET
Last 30 days
Recent Press Releases & News
lean bull
▲ 6
● 19
▼ 0
Abbott (ABT) Exceeds Market Returns: Some Facts to Consider
Abbott Introduces America’s First Liquid Baby Formula With Whole Milk
Abbott Laboratories Stock: Is ABT Underperforming the Healthcare Sector?
Overview
52-week range
$82
$137
47% of range
Avg surprise (last 2)
+0.4%
Avg reaction (last 1)
-8.5%
0% positive
Latest IV / EM
34%
EM ±1.4% · $109 · Sep 4
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Mar 31, 2026 | Mar 2026 | $0.61 | — | — | — | — | financials |
| Wed Oct 15, 2025 | Sep/2025 | $1.30 | $1.30 | 0.0% | — | — | earnings |
| Thu Jul 17, 2025 | Jun/2025 | $1.26 | $1.25 | +0.8% | — | -8.5% | earnings |
| Mon Mar 31, 2025 | Mar 2025 | $0.76 | — | — | — | — | financials |
| Mon Sep 30, 2024 | Sep 2024 | $0.94 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.74 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.70 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.82 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.78 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $0.75 | — | — | — | — | financials |
| Fri Sep 30, 2022 | Sep 2022 | $0.81 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $11.16B | — | $11.37B | $11.14B | $10.36B | — | $10.63B | $10.38B |
| Cost of revenue | $4.89B | — | $5.08B | $4.85B | $4.47B | — | $4.70B | $4.60B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $1.34B | — | $2.06B | $2.05B | $1.69B | — | $1.86B | $1.67B |
| Net income | $1.08B | — | $1.64B | $1.78B | $1.32B | — | $1.65B | $1.30B |
| EPS (diluted) | $0.61 | — | $0.94 | $1.01 | $0.76 | — | $0.94 | $0.74 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $6.80B | $8.52B | $7.51B | $6.95B | $6.53B | $7.62B | $7.56B | $6.99B |
| Inventory | $6.99B | $6.49B | $6.71B | $6.95B | $6.64B | $6.19B | $6.81B | $6.81B |
| Total current assets | $25.51B | $26.00B | $24.84B | $24.47B | $23.15B | $23.66B | $23.80B | $23.12B |
| Total assets | $110.43B | $86.71B | $84.18B | $84.00B | $81.45B | $81.41B | $74.36B | $73.02B |
| Long-term debt | $29.64B | $9.90B | $11.60B | $12.93B | $12.74B | $12.62B | $12.82B | $13.14B |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $52.06B | $52.13B | $50.95B | $50.56B | $48.81B | $47.66B | $39.80B | $39.32B |